BRPI0907938A2 - Painel de biomarcadores de carcinoma de pequenas células do pulmão - Google Patents

Painel de biomarcadores de carcinoma de pequenas células do pulmão

Info

Publication number
BRPI0907938A2
BRPI0907938A2 BRPI0907938-6A BRPI0907938A BRPI0907938A2 BR PI0907938 A2 BRPI0907938 A2 BR PI0907938A2 BR PI0907938 A BRPI0907938 A BR PI0907938A BR PI0907938 A2 BRPI0907938 A2 BR PI0907938A2
Authority
BR
Brazil
Prior art keywords
small cell
cell carcinoma
biomarker panel
lung small
carcinoma biomarker
Prior art date
Application number
BRPI0907938-6A
Other languages
English (en)
Inventor
Ann Vander Borght
Franciscus Charles Servatius Ramaekers
Stefan Maarten Van Den Eijnde
Marjan Harmsma
Frank Walter Falkenberg
Gereon Poschmann
Kaï STÜHLER
Helmuth Erich Meyer
Günter KLOPPEL
Original Assignee
Mubio Products Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mubio Products Bv filed Critical Mubio Products Bv
Publication of BRPI0907938A2 publication Critical patent/BRPI0907938A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Nuclear Medicine (AREA)
BRPI0907938-6A 2008-02-22 2009-02-19 Painel de biomarcadores de carcinoma de pequenas células do pulmão BRPI0907938A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0803192.4A GB0803192D0 (en) 2008-02-22 2008-02-22 SCLC biomarker panel
PCT/EP2009/001215 WO2009103542A1 (en) 2008-02-22 2009-02-19 Small cell lung carcinoma biomarker panel

Publications (1)

Publication Number Publication Date
BRPI0907938A2 true BRPI0907938A2 (pt) 2015-07-28

Family

ID=39284335

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907938-6A BRPI0907938A2 (pt) 2008-02-22 2009-02-19 Painel de biomarcadores de carcinoma de pequenas células do pulmão

Country Status (12)

Country Link
US (1) US20110053156A1 (pt)
EP (1) EP2274618A1 (pt)
JP (1) JP2011517341A (pt)
CN (1) CN102084253A (pt)
AU (1) AU2009216910A1 (pt)
BR (1) BRPI0907938A2 (pt)
CA (1) CA2712204A1 (pt)
EA (1) EA201070834A1 (pt)
GB (1) GB0803192D0 (pt)
MX (1) MX2010009103A (pt)
WO (1) WO2009103542A1 (pt)
ZA (1) ZA201004946B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147019A (en) 2002-03-13 2012-10-15 Biogen Idec Inc Anti-alpha v beta 6 antibodies
CN102875681A (zh) 2005-07-08 2013-01-16 拜奥根Idec马萨诸塞公司 抗-αvβ6抗体及其用途
US8700335B2 (en) 2006-05-18 2014-04-15 Caris Mpi, Inc. System and method for determining individualized medical intervention for a disease state
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
BRPI0714381A2 (pt) 2006-07-10 2013-03-05 Biogen Idec Inc composiÇÕes e mÉtodos para inibir crescimento de cÂnceres deficientes em smad4
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
EP2350320A4 (en) 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
JP6114035B2 (ja) 2010-02-10 2017-04-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 肺癌検出用唾液バイオマーカー
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
JP5905003B2 (ja) 2010-07-09 2016-04-20 ソマロジック・インコーポレーテッド 肺癌バイオマーカーとその使用
MX350533B (es) 2010-08-13 2017-09-08 Somalogic Inc Biomarcadores de cancer pancreatico y usos de los mismos.
WO2012108538A1 (ja) * 2011-02-10 2012-08-16 国立大学法人 長崎大学 急性肺損傷診断方法
BR112014006432B8 (pt) * 2011-10-24 2022-10-25 Somalogic Inc Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador
US20150086570A1 (en) * 2012-03-29 2015-03-26 Biogen Idec Ma Inc. Biomarkers for use in integrin therapy applications
US10035859B2 (en) 2013-03-15 2018-07-31 Biogen Ma Inc. Anti-alpha V beta 6 antibodies and uses thereof
WO2014143739A2 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Anti-alpha v beta 6 antibodies and uses thereof
CN104374918B (zh) * 2013-08-17 2016-11-09 复旦大学 热休克蛋白47胶质瘤相关肿瘤抗原及应用
CN106061998B (zh) * 2014-02-05 2020-12-11 弗吉瑞必欧诊断股份公司 用于检测恶性赘生性疾病的组合物和方法
CN108139381A (zh) * 2015-06-26 2018-06-08 百奥马克癌症系统公司 肺癌检测方法
CN106432492A (zh) * 2015-08-07 2017-02-22 广州瑞博奥生物技术有限公司 针对肿瘤标志物建立的抗体组合及其elisa方法
GB2568297A (en) * 2017-11-13 2019-05-15 Univ Stellenbosch Method of Detecting Inflammation
US20210378992A1 (en) * 2018-10-19 2021-12-09 Auransa Inc. Methods for treating a subtype of small cell lung cancer
CN109387633A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的肺癌检测系统及方法
CN113766914B (zh) 2018-12-20 2024-02-13 美商奥润沙公司 戊烷脒的类似物和其用途
US20220145397A1 (en) * 2019-03-08 2022-05-12 Oncolab Diagnostics Gmbh Cancer diagnosis and prognosis
CN110333352A (zh) * 2019-08-07 2019-10-15 基因科技（上海）股份有限公司 肿瘤相关自身抗体及肿瘤标志物联合检测试剂盒
CN113061184B (zh) * 2021-04-25 2022-07-01 福州迈新生物技术开发有限公司 抗ck7蛋白单克隆抗体及其细胞株、制备方法和应用
CN113801937A (zh) * 2021-10-22 2021-12-17 中日友好医院(中日友好临床医学研究所) 一种用于诊断肺癌的产品
CN114729055B (zh) * 2022-02-24 2023-01-24 青岛华赛伯曼医学细胞生物有限公司 共表达CD45和EpCAM的细胞群的检测和分离方法及其用途
CN115851927A (zh) * 2022-08-09 2023-03-28 上海善准医疗科技有限公司 肺鳞癌分子分型及生存风险基因群及诊断产品和应用
CN115948548B (zh) * 2022-09-09 2025-09-16 中国人民解放军军事科学院军事医学研究院 一种与非小细胞肺癌发生发展相关的circRNA及其应用
CN120442544A (zh) * 2024-02-07 2025-08-08 上海恩元生物科技有限公司 一种人血浆神经源性外泌体和总外泌体及其分离方法
CN119757766A (zh) * 2024-12-24 2025-04-04 上海市肺科医院（上海市职业病防治院） 预测非小细胞肺癌免疫治疗疗效的生物标志物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2144750A1 (en) * 1992-09-17 1994-03-31 Rolf Stahel Tumor-specific antibodies and antigen
AU2007224704B2 (en) * 2006-03-13 2012-12-06 Novovacs Holding B.V. Cancer vaccine

Also Published As

Publication number Publication date
GB0803192D0 (en) 2008-04-02
CN102084253A (zh) 2011-06-01
JP2011517341A (ja) 2011-06-02
EA201070834A1 (ru) 2011-02-28
MX2010009103A (es) 2011-01-21
ZA201004946B (en) 2012-12-27
US20110053156A1 (en) 2011-03-03
WO2009103542A1 (en) 2009-08-27
CA2712204A1 (en) 2009-08-27
EP2274618A1 (en) 2011-01-19
AU2009216910A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
ZA201004946B (en) Small cell lung carcinoma biomarker panel
EP2340506A4 (en) BIOMARKER FOR LUNG CANCER AND USE
BRPI0920069A2 (pt) biomarcadores
BRPI1006075A2 (pt) biomarcadores de cancer
EP2265642A4 (en) BIOMARKERS
EP2373999A4 (en) NEW BIOMARKERS
BRPI0913294A2 (pt) touchpad virtual
EP2339910A4 (en) GLASSHOUSE
PL2245464T3 (pl) Biomarkery p53
FI20070691L (fi) Paneelirakenne
EP2129285A4 (en) Analyte sensor
EP2220124A4 (en) DETECTION OF BIOMARKERS
BRPI0814572A2 (pt) Célula de lítio
EP2263086A4 (en) BIOMARKERS
EP2304128A4 (en) PLATE CONSTRUCTION
FI20086002A0 (fi) Paneeli
BRPI0813726A2 (pt) Célula de lítio
GB0818660D0 (en) Biomarkers
IL213510A (en) Biomarker
EP2265641A4 (en) BIOMARKERS
FR2922250B1 (fr) Volet battant isolant
GB0807214D0 (en) Biomarkers
EP2501845A4 (en) KREBSBIOMARKER
DK2142905T3 (da) Biomarkørnormalisering
AT507234A3 (de) Sonnenkollektor

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.